London, England, United Kingdom
Passionate about the intersection of healthcare, strategy, and innovation, my primary interests lie in roles that blend consulting and healthtech. I'm currently a final year BSc Biomedical Sciences student at the University College London (UCL), ranked within the top 10 universities globally, specialising in the Drug Mechanisms (Pharmacology) stream. My experience thus far has spanned scientific and market research, statistical analysis and impact-driven strategy as I believe in bridging innovative advancements with real-world execution. As I continue to expand my skills, I’m eager to explore diverse opportunities to gain hands-on experience. I’m always open to meaningful discussions and collaborations - let’s connect.
Delivered 3 stakeholder presentations and strategic recommendations for a $1.3M Seed A funded biotech startup by conducting market research, analysing scientific literature, and collaborating with a multidisciplinary team of 5 to align evidence with stakeholder needs.
IDEA Society is the only UCL Society focused on emerging economies. We are part of an international network based in London called IDEAS Globally, which provides any globally-minded student the opportunity to become involved with international development. We change lives by building social enterprises in emergent countries throughout the world.
Conducted an independent research project in the Bianco lab examining how the application of pharmacology on specific serotonergic receptors can influence behavioural decision-making in larval zebrafish. Designed behavioural assays to isolate cognitive versus motor effects, and performed analysis of data using MATLAB and Python, applying statistical modelling to quantify changes.
Worked towards Sertie's entry into an international market. Previously enhanced outreach to numerous student societies across the UK, established LinkedIn and Instagram outreach, and developed comprehensive marketing packs to support initiatives.
Cross-functional exposure across Preclinical, Clinical, Intellectual Property and Regulatory Affairs teams working on the provision of mesenchymal stem cell treatment and multicellular immunotherapy in the Asia-Pacific region.